Inherited MST1 deficiency underlies susceptibility to EV-HPV infections

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Crequer, Amandine ^a,b   Picard, Capucine ^b,c,d   Patin, Etienne ^e   D'Amico, Aurelia ^a   Abhyankar, Avinash ^a   Munzer, Martine ^f   Debré, Marianne ^d   Zhang, Shen Ying ^a,c   de Saint Basile, Geneviève ^g   Fischer, Alain ^b,d,g   Abel, Laurent ^a,b,c   Orth, Gérard ^e   Casanova, Jean Laurent ^a,b,c,d   Jouanguy, Emmanuelle ^a,b,c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c IMAGINE INSTITUTE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e INSTITUT PASTEUR   (France)

^f AMERICAN MEMORIAL HOSPITAL   (France)

^g INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; COTRIMOXAZOLE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FLUCONAZOLE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; MEASLES MUMPS RUBELLA VACCINE; PROTEIN SERINE THREONINE KINASE; SERINE THREONINE KINASE 4; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BACTERIAL INFECTION; BRONCHITIS; CANDIDA ALBICANS; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHICKENPOX; CHILD; ENZYME DEFICIENCY; EPIDERMODYSPLASIA VERRUCIFORMIS; EPSTEIN BARR VIRUS INFECTION; EXON; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN TISSUE; IMMUNOPHENOTYPING; INFECTION; INTENSIVE CARE; LINKAGE ANALYSIS; LYMPHADENECTOMY; MALE; MST1 DEFICIENCY; MST1 GENE; MYCOSIS; NONSENSE MUTATION; PEDIGREE ANALYSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN BLOTTING; WART VIRUS;

ADOLESCENT; AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BASE SEQUENCE; CELL PROLIFERATION; CHILD; CODON, NONSENSE; EPIDERMODYSPLASIA VERRUCIFORMIS; EXOME; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE GROWTH FACTOR; HOMOZYGOTE; HUMANS; IMMUNOPHENOTYPING; INFANT; INHERITANCE PATTERNS; MALE; MITOGENS; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PROTO-ONCOGENE PROTEINS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84865429528     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044010     Document Type: Article

References (50)

1. Orth G, (2006) Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 18: 362-374.
2. Orth G, (2008) Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis. Curr Top Microbiol Immunol 321: 59-83.
3. Cockayne E (1933) Inherited abnormalities of the skin and its appendages. Oxford University Press, London.
4. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, et al. (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32: 579-581.
5. Casanova JL, Abel L, (2005) Inborn errors of immunity to infection: the rule rather than the exception. J Exp Med 202: 197-201.
6. Casanova JL, Abel L, (2007) Primary immunodeficiencies: a field in its infancy. Science 317: 617-619.
7. Alcais A, Abel L, Casanova JL, (2009) Human genetics of infectious diseases: between proof of principle and paradigm. J Clin Invest 119: 2506-2514.
8. Alcais A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, et al. (2010) Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity? Ann N Y Acad Sci 1214: 18-33.
9. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, et al. (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205: 35-42.
10. Aochi S, Nakanishi G, Suzuki N, Setsu N, Suzuki D, et al. (2007) A novel homozygous mutation of the EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. Br J Dermatol 157: 1265-1266.
11. Berthelot C, Dickerson MC, Rady P, He Q, Niroomand F, et al. (2007) Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol 56: 882-886.
12. Gober MD, Rady PL, He Q, Tucker SB, Tyring SK, et al. (2007) Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient. J Invest Dermatol 127: 817-820.
13. Zuo YG, Ma D, Zhang Y, Qiao J, Wang B, (2006) Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis. J Dermatol Sci 44: 153-159.
14. Sun XK, Chen JF, Xu AE, (2005) A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol 30: 573-574.
15. Tate G, Suzuki T, Kishimoto K, Mitsuya T, (2004) Novel mutations of EVER1/TMC6 gene in a Japanese patient with epidermodysplasia verruciformis. J Hum Genet 49: 223-225.
16. Rady PL, De Oliveira WR, He Q, Festa C, Rivitti EA, et al. (2007) Novel homozygous nonsense TMC8 mutation detected in patients with epidermodysplasia verruciformis from a Brazilian family. Br J Dermatol 157: 831-833.
17. Crequer A, Troeger A, Patin E, Ma CS, Picard C, et al. (2012) Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. Journal of Clinical Investigation in Press.
18. Rogers HD, Macgregor JL, Nord KM, Tyring S, Rady P, et al. (2009) Acquired epidermodysplasia verruciformis. J Am Acad Dermatol 60: 315-320.
19. Daly ML, Hay RJ (2012) Epidermodysplasia verruciformis and human immunodeficiency virus infection: a distinct entity? Curr Opin Infect Dis.
20. Lutzner MA, (1985) Papillomavirus lesions in immunodepression and immunosuppression. Clin Dermatol 3: 165-169.
21. Gross G, Ellinger K, Roussaki A, Fuchs PG, Peter HH, et al. (1988) Epidermodysplasia verruciformis in a patient with Hodgkin's disease: characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol 91: 43-48.
22. Laffort C, Le Deist F, Favre M, Caillat-Zucman S, Radford-Weiss I, et al. (2004) Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 363: 2051-2054.
23. Byun M, Abhyankar A, Lelarge V, Plancoulaine S, Palanduz A, et al. (2010) Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med 207: 2307-2312.
24. Bolze A, Byun M, McDonald D, Morgan NV, Abhyankar A, et al. (2010) Whole-exome-sequencing-based discovery of human FADD deficiency. Am J Hum Genet 87: 873-881.
25. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S,et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208: 1635-1648.
26. Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, et al. (2007) Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J Immunol 178: 4112-4119.
27. Eller MS, Maeda T, Magnoni C, Atwal D, Gilchrest BA, (1997) Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A 94: 12627-12632.
28. Weeda G, Ma LB, van Ham RC, van der Eb AJ, Hoeijmakers JH, (1991) Structure and expression of the human XPBC/ERCC-3 gene involved in DNA repair disorders xeroderma pigmentosum and Cockayne's syndrome. Nucleic Acids Res 19: 6301-6308.
29. Oh KS, Khan SG, Jaspers NG, Raams A, Ueda T, et al. (2006) Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome. Hum Mutat 27: 1092-1103.
30. Nehme NT, Pachlopnik Schmid J, Debeurme F, Andre-Schmutz I, Lim A, et al. (2011) MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T cells survival. Blood 10.1182/blood-2011-09-378364.
31. Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, et al. (2012) The phenotype of human STK4 deficiency. Blood 10.1182/blood-2011-09-378158.
32. Zhou D, Medoff BD, Chen L, Li L, Zhang XF, et al. (2008) The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naive T cells. Proc Natl Acad Sci U S A 105: 20321-20326.
33. Dong Y, Du X, Ye J, Han M, Xu T, et al. (2009) A cell-intrinsic role for Mst1 in regulating thymocyte egress. J Immunol 183: 3865-3872.
34. Avruch J, Zhou D, Fitamant J, Bardeesy N, (2011) Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development. Br J Cancer 104: 24-32.
35. Lee JH, Kim TS, Yang TH, Koo BK, Oh SP, et al. (2008) A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J 27: 1231-1242.
36. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, et al. (2011) Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144: 782-795.
37. Tan MJ, White EA, Sowa ME, Harper JW, Aster JC, et al. (2012) Cutaneous beta-human papillomavirus E6 proteins bind Mastermind-like coactivators and repress Notch signaling. Proc Natl Acad Sci U S A 109: E1473-1480.
38. Abecasis GR, Cherny SS, Cookson WO, Cardon LR, (2002) Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30: 97-101.
39. Wang K, Chen Z, Tadesse MG, Glessner J, Grant SF, et al. (2008) Modeling genetic inheritance of copy number variations. Nucleic Acids Res 36: e138.
40. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
41. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297-1303.
42. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
43. Tunnacliffe A, Olsson C, de la Hera A, (1989) The majority of human CD3 epitopes are conferred by the epsilon chain. Int Immunol 1: 546-550.
44. Andre-Schmutz I, Le Deist F, Hacein-Bey-Abina S, Vitetta E, Schindler J, et al. (2002) Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 360: 130-137.
45. de Saint Basile G, Geissmann F, Flori E, Uring-Lambert B, Soudais C, et al. (2004) Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3. J Clin Invest 114: 1512-1517.
46. de Villartay JP, Lim A, Al-Mousa H, Dupont S, Dechanet-Merville J, et al. (2005) A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest 115: 3291-3299.
47. Lugada ES, Mermin J, Kaharuza F, Ulvestad E, Were W, et al. (2004) Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol 11: 29-34.
48. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, et al. (2003) Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112: 973-980.
49. Bisset LR, Lung TL, Kaelin M, Ludwig E, Dubs RW, (2004) Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. Eur J Haematol 72: 203-212.
50. Eidenschenk C, Jouanguy E, Alcais A, Mention JJ, Pasquier B, et al. (2006) Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes. J Immunol 177: 8835-8843.